1007125-06-5

Usage

Uses

Used in Pharmaceutical Research:
(1R,4S,5R,6S)-tert-butyl 5,6-dihydroxy-3-oxo-2-aza-bicyclo[2.2.1]heptane-2-carboxylate is used as a research compound for exploring its potential pharmaceutical applications. The presence of multiple functional groups and a unique bicyclic structure may offer opportunities for the development of new drugs or drug candidates, particularly in areas where its specific chemical properties could be leveraged for therapeutic effects.
Used in Chemical Research:
In the field of chemical research, (1R,4S,5R,6S)-tert-butyl 5,6-dihydroxy-3-oxo-2-aza-bicyclo[2.2.1]heptane-2-carboxylate serves as a subject for studying the properties and reactions of complex organic molecules. Its unique structure and functional groups can be investigated to understand how they influence chemical behavior, potentially leading to advancements in synthetic chemistry or the discovery of new chemical processes.
Without additional information on specific applications or industries, these general uses in pharmaceutical and chemical research provide a starting point for understanding the potential relevance of (1R,4S,5R,6S)-tert-butyl 5,6-dihydroxy-3-oxo-2-aza-bicyclo[2.2.1]heptane-2-carboxylate in scientific and industrial contexts. Further research and development would be necessary to fully realize its practical applications and benefits.

Upstream product

• 24424-99-5 di-tert-butyl dicarbonate 
• 79200-56-9 (-)-2-azabicyclo[2.2.1]hept-5-en-3-one 
• 200002-41-1 (-)-[(1R,4S)-tert-butyl 3-oxo-2-azabicyclo(2.2.1)hept-5-ene-2-carboxylate] 
• 49805-30-3 racemic 2-azabicyclo[2.2.1]hept-5-en-3-one 
• 151792-53-9 tert-butyl (1R,4S)-(-)-3-oxo-2-azabicyclo[2.2.1]hept-5-ene-2-carboxylate 

Downstream Products

• 1007125-07-6 tert-butyl (1R,4S,5R,6S)-5,6-bis(benzoyloxy)-3-oxo-2-azabicyclo[2.2.1]heptane-2-carboxylate 
• 1208988-90-2 C₁₇H₁₉NO₅ 
• 1450975-28-6 (+)-(1R,2S,5R)-5-(hydroxymethyl)cyclopent-3-ene-1,2-diyl dibenzoate 
• 1007125-09-8 (-)-(1R,2S,3R,5R)-3-amino-5-(hydroxymethyl)cyclopentane-1,2-diyl dibenzoate hydrochloride 
• 1007125-08-7 (-)-(1R,2S,3R,5R)-3-((tert-butoxycarbonyl)amino)-5-(hydroxymethyl)cyclopentane-1,2-diyl dibenzoate 

Relevant academic research and scientific papers

RNAs Containing Carbocyclic Ribonucleotides

Toward the goal of evaluation of carbocyclic ribonucleoside-containing oligonucleotide therapeutics, we developed convenient, scalable syntheses of all four carbocyclic ribonucleotide phosphoramidites and the uridine solid-support building block. Crystall

CARBOCYCLIC NUCLEOSIDE ANALOGUE

The present invention relates to novel hydrolytically stable carbocyclic 5-aza-2-deoxycytidine and carbocyclic 5-aza-cytidine compounds and prodrugs thereof as hypomethylating agents.

Efficient and stereoselective synthesis of 2′-fluoro-6′-methylene-carbocyclic adenosine (FMCA)

The invention provides a new convergent approach for the synthesis of 2′-fluoro-6′-methylene-carbocyclic adenosine (FMCA) from a readily available starting material (Vince lactam) in fourteen steps. An efficient and practical methodology for stereospecifi

Stereoselective synthesis of 2′-fluoro-6′-methylene carbocyclic adenosine via Vince lactam

2′-Fluoro-6′-methylene carbocyclic adenosine (FMCA) is a potent and selective inhibitor of wild type as well as drug-resistant hepatitis B virus (HBV) mutants. FMCA demonstrated excellent anti-HBV activity against both adefovir-resistant and lamivudine-re

Heteroaryl compounds useful as inhibitors of E1 activating enzymes

This invention relates to compounds that inhibit E1 activating enzymes, pharmaceutical compositions comprising the compounds, and methods of using the compounds. The compounds are useful for treating disorders, particularly cell proliferation disorders, including cancers, inflammatory and neurodegenerative disorders; and inflammation associated with infection and cachexia.